Life Sciences Companies Navigate Path to Market

Law360

"Public markets are showing signs of life for capital-hungry life science companies, which are completing offerings despite volatility caused by the coronavirus pandemic, creating challenges for lawyers charged with crafting up-to-date disclosures amid unprecedented uncertainty."

Read the article (subscription required)

Related Contacts
Charlie Kim Partner, San Diego